- Home
- DHT vs KYMR Comparison
DHT vs KYMR Comparison
Compare DHT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- KYMR
- Stock Information
- Founded
- DHT 2005
- KYMR 2015
- Country
- DHT Bermuda
- KYMR United States
- Employees
- DHT N/A
- KYMR N/A
- Industry
- DHT Marine Transportation
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- DHT Consumer Discretionary
- KYMR Health Care
- Exchange
- DHT Nasdaq
- KYMR Nasdaq
- Market Cap
- DHT 1.6B
- KYMR 1.8B
- IPO Year
- DHT 2005
- KYMR 2020
- Fundamental
- Price
- DHT $11.08
- KYMR $30.07
- Analyst Decision
- DHT Strong Buy
- KYMR Buy
- Analyst Count
- DHT 4
- KYMR 13
- Target Price
- DHT $13.75
- KYMR $56.69
- AVG Volume (30 Days)
- DHT 1.6M
- KYMR 690.7K
- Earning Date
- DHT 05-06-2025
- KYMR 05-09-2025
- Dividend Yield
- DHT 7.30%
- KYMR N/A
- EPS Growth
- DHT 4.76
- KYMR N/A
- EPS
- DHT 1.10
- KYMR N/A
- Revenue
- DHT $563,104,000.00
- KYMR $58,885,000.00
- Revenue This Year
- DHT N/A
- KYMR $16.24
- Revenue Next Year
- DHT $25.01
- KYMR $22.41
- P/E Ratio
- DHT $10.03
- KYMR N/A
- Revenue Growth
- DHT N/A
- KYMR N/A
- 52 Week Low
- DHT $8.67
- KYMR $19.45
- 52 Week High
- DHT $12.80
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- DHT 58.49
- KYMR 49.08
- Support Level
- DHT $10.80
- KYMR $28.28
- Resistance Level
- DHT $11.43
- KYMR $35.98
- Average True Range (ATR)
- DHT 0.29
- KYMR 2.26
- MACD
- DHT 0.08
- KYMR -0.10
- Stochastic Oscillator
- DHT 76.64
- KYMR 30.31
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.